Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
China · Delayed Price · Currency is CNY 2.990
+0.020 (0.67%)
Jul 22, 2026, 3:04 PM CST
SHE:002198 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 1,476 | 3,568 | 3,715 | 3,695 | 3,309 | 3,999 | |
Market Cap Growth | -56.84% | -3.96% | 0.55% | 11.66% | -17.26% | 75.89% |
Enterprise Value | 1,344 | 3,440 | 3,418 | 3,409 | 3,102 | 3,818 |
Last Close Price | 2.97 | 7.03 | 7.32 | 7.23 | 6.47 | 7.82 |
PE Ratio | 58.10 | 117.06 | 180.24 | 107.65 | 75.32 | 2707.14 |
Forward PE | - | 21.70 | 21.70 | 21.70 | 21.70 | 21.70 |
PS Ratio | 3.83 | 9.30 | 9.88 | 6.93 | 5.02 | 6.96 |
PB Ratio | 2.02 | 4.97 | 4.90 | 4.84 | 4.54 | 5.84 |
P/TBV Ratio | 2.16 | 5.31 | 5.22 | 5.16 | 4.89 | 6.39 |
P/FCF Ratio | - | - | 167.76 | 39.56 | 135.53 | 80.86 |
P/OCF Ratio | - | 396.33 | 61.05 | 37.53 | 121.86 | 77.20 |
EV/Sales Ratio | 3.49 | 8.96 | 9.09 | 6.39 | 4.71 | 6.64 |
EV/EBITDA Ratio | 24.04 | 55.77 | 84.67 | 57.03 | 40.76 | 66.18 |
EV/EBIT Ratio | 39.13 | 84.94 | 164.76 | 95.87 | 61.78 | 130.33 |
EV/FCF Ratio | - | - | 154.35 | 36.50 | 127.07 | 77.19 |
Debt / Equity Ratio | 0.03 | - | - | - | - | 0.05 |
Debt / EBITDA Ratio | 0.36 | - | - | - | - | 0.54 |
Debt / FCF Ratio | - | - | - | - | - | 0.63 |
Net Debt / Equity Ratio | -0.18 | -0.25 | -0.44 | -0.44 | -0.32 | -0.31 |
Net Debt / EBITDA Ratio | -2.37 | -2.87 | -8.33 | -5.62 | -3.10 | -3.67 |
Net Debt / FCF Ratio | 1.06 | 1.76 | -15.18 | -3.59 | -9.67 | -4.28 |
Asset Turnover | 0.45 | 0.46 | 0.45 | 0.63 | 0.80 | 0.71 |
Inventory Turnover | 2.79 | 1.98 | 1.79 | 2.23 | 2.95 | 1.96 |
Quick Ratio | 3.26 | 3.70 | 10.23 | 9.93 | 5.56 | 4.58 |
Current Ratio | 4.25 | 5.22 | 12.15 | 11.76 | 6.72 | 5.57 |
Return on Equity (ROE) | 3.79% | 4.13% | 2.71% | 4.60% | 6.22% | 0.22% |
Return on Assets (ROA) | 2.52% | 3.00% | 1.54% | 2.62% | 3.79% | 2.27% |
Return on Invested Capital (ROIC) | 5.24% | 6.75% | 4.01% | 6.74% | 8.95% | 1.44% |
Return on Capital Employed (ROCE) | 4.50% | 5.40% | 2.60% | 4.50% | 6.60% | 4.10% |
Earnings Yield | 1.86% | 0.85% | 0.56% | 0.93% | 1.33% | 0.04% |
FCF Yield | -8.47% | -2.83% | 0.60% | 2.53% | 0.74% | 1.24% |
Dividend Yield | - | - | - | 0.69% | - | - |
Payout Ratio | - | - | 123.24% | - | - | - |
Buyback Yield / Dilution | -6.15% | 0.11% | 0.00% | -0.07% | 0.41% | -0.40% |
Total Shareholder Return | -6.15% | 0.11% | 0.00% | 0.62% | 0.41% | -0.40% |